UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2 Journal article
Rao, Xia, Zhao, Runchu, Tong, Zhou, Guo, Shuxin, Peng, Weiyu, Liu, Kefang, Li, Shihua, Wu, Lili, Tong, Jianyu, Chai, Yan, Han, Pu, Wang, Feiran, Jia, Peng, Li, Zhaohui, Zhao, Xin, Li, Dedong, Zhang, Rong, Zhang, Xue, Zou, Weiwei, Li, Weiwei, Wang, Qihui, Gao, George Fu, Wu, Yan, Dai, Lianpan, Gao, Feng. Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2[J]. Proceedings of the National Academy of Sciences of the United States of America, 2023, 120(52), e2314193120.
Authors:  Rao, Xia;  Zhao, Runchu;  Tong, Zhou;  Guo, Shuxin;  Peng, Weiyu; et al.
Favorite | TC[WOS]:8 TC[Scopus]:9  IF:9.4/10.8 | Submit date:2024/01/02
Cryptic Epitope  Neutralizing Antibody  Omicron Ba.4/ba.5/bq.1.1/xbb Subvariant  Rbd-8  Sars-cov-2  
Formosanin C inhibits non-small-cell lung cancer progression by blocking MCT4/CD147-mediated lactate export Journal article
Li, Jiaqi, Wu, Zongjin, Chen, Geer, Wang, Xiaoxuan, Zhu, Xiaoyu, Zhang, Yao, Zhang, Ren, Wu, Weiyu, Zhu, Yizhun, Ma, Lijuan, Yu, Haijie. Formosanin C inhibits non-small-cell lung cancer progression by blocking MCT4/CD147-mediated lactate export[J]. Phytomedicine, 2023, 109.
Authors:  Li, Jiaqi;  Wu, Zongjin;  Chen, Geer;  Wang, Xiaoxuan;  Zhu, Xiaoyu; et al.
Favorite | TC[WOS]:6 TC[Scopus]:6  IF:6.7/6.2 | Submit date:2023/10/26
CD147  Formosanin C (FC)  Lactate  MCT4  NSCLC  
Celastrol inhibits lung cancer growth by triggering histone acetylation and acting synergically with HDAC inhibitors Journal article
Chen, Geer, Zhu, Xiaoyu, Li, Jiaqi, Zhang, Yao, Wang, Xiaoxuan, Zhang, Ren, Qin, Xinchen, Chen, Xi, Wang, Junyi, Liao, Weilin, Wu, Zongjin, Lu, Lu, Wu, Weiyu, Yu, Haijie, Ma, Lijuan. Celastrol inhibits lung cancer growth by triggering histone acetylation and acting synergically with HDAC inhibitors[J]. Pharmacological Research, 2022, 185.
Authors:  Chen, Geer;  Zhu, Xiaoyu;  Li, Jiaqi;  Zhang, Yao;  Wang, Xiaoxuan; et al.
Favorite | TC[WOS]:16 TC[Scopus]:17  IF:9.1/9.0 | Submit date:2023/01/31
Acetylation  Anacardic ACid (Pubchem Cid: 167551)  C646 (Pubchem Cid: 1285941)  Celastrol  Celastrol (Pubchem Cid: 122724)  Ci994 (Pubchem Cid: 2746)  Hdac  Histone Modification  Lung Cancer  Mc1568 (Pubchem Cid: 71311876)  Ms275 (Pubchem Cid: 4261)  Nu9056 (Pubchem Cid: 72201043)  Saha (Pubchem Cid: 5311)  
The key role of sphingolipid metabolism in cancer: New therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistance Journal article
Li RunZe, Wang XuanRun, Wang Jian, Xie Chun, Wang XingXia, Pan HuDan, Meng WeiYu, Liang TuLiang, Li JiaXin, Yan PeiYu, Wu QiBiao, Liu Liang, Yao XiaoJun, Leung Elaine Lai Han. The key role of sphingolipid metabolism in cancer: New therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistance[J]. Frontiers in Oncology, 2022.
Authors:  Li RunZe;  Wang XuanRun;  Wang Jian;  Xie Chun;  Wang XingXia; et al.
Favorite |   IF:3.5/4.0 | Submit date:2023/06/15